Fluticasone Nasal Spray Administration and Efficacy

Administration Guidelines

Proper administration technique for fluticasone propionate nasal spray includes priming the bottle before first use, shaking the bottle prior to spraying, blowing the nose prior to using the spray, keeping the head in an upright position during administration, and breathing in gently during spraying, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 1

Headache, pharyngitis, epistaxis (nose bleeds), nasal burning or irritation are common side effects of fluticasone propionate nasal spray, according to the American Academy of Otolaryngology-Head and Neck Surgery 2, 3
Nausea or vomiting, asthma symptoms, and cough may also occur as side effects of fluticasone propionate nasal spray, as reported by the American Academy of Otolaryngology-Head and Neck Surgery 2, 3
Local side effects such as nasal irritation and bleeding are rare and can be minimized with proper administration technique, as noted by the American Academy of Otolaryngology-Head and Neck Surgery 1

A history of hypersensitivity to fluticasone propionate or its components is a contraindication for use, according to the American Academy of Otolaryngology-Head and Neck Surgery 2, 3

Fluticasone propionate is effective for both seasonal and perennial allergic rhinitis, as reported by the American Academy of Otolaryngology-Head and Neck Surgery 2, 3

Onset of action may be delayed (12 hours) with maximal efficacy reached in days to weeks, and regular use rather than as-needed approach is generally recommended to maintain optimal symptom control, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 1

For children aged 4–11 years, the recommended regimen is 1 spray (50 µg) per nostril once daily, providing a total daily dose of 100 µg; this recommendation is supported by the American Academy of Otolaryngology‑Head and Neck Surgery. 4

The most frequently reported adverse events with intranasal fluticasone propionate in children are headache, pharyngitis, epistaxis, and nasal burning or irritation, as documented by the American Academy of Otolaryngology‑Head and Neck Surgery. 4

A documented hypersensitivity to fluticasone propionate or any component of its formulation constitutes a contraindication to its use, according to the American Academy of Otolaryngology‑Head and Neck Surgery. 4

Fluticasone propionate is approved for use in children starting at age 4 years; by contrast, mometasone furoate and triamcinolone acetonide receive approval for children as young as 2 years, and budesonide is approved only for ages ≥ 6 years, as reported by the American Academy of Otolaryngology‑Head and Neck Surgery. 4
Fluticasone propionate provides the advantage of once‑daily dosing while maintaining demonstrated efficacy at lower doses in pediatric patients, a benefit highlighted by the American Academy of Otolaryngology‑Head and Neck Surgery. 4